Geneos Wealth Management’s Strive Emerging Markets ex-China ETF STXE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9K Hold
200
– – ﹤0.01% 2388
2026
Q2
$10.5K Hold
200
– – ﹤0.01% 2008
2026
Q1
$7.82K Hold
200
– – ﹤0.01% 2052
2025
Q4
$7.18K Hold
200
– – ﹤0.01% 2055
2025
Q3
$6.58K Hold
200
– – ﹤0.01% 2080
2025
Q2
$6.2K Hold
200
– – ﹤0.01% 2503
2025
Q1
$5.46K Hold
200
– – ﹤0.01% 2487
2024
Q4
$5.51K Buy
+200
New +$5.86K ﹤0.01% 2296

Other funds holding STXE

Geneos Wealth Management's STXE Position: Q3 2026 in Review

Geneos Wealth Management held its Strive Emerging Markets ex-China ETF (STXE) position steady in Q3 2026 at 200 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Geneos Wealth Management first reported a position in STXE in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.5K in Q2 2026. 24 funds tracked by Wall St. Rank hold STXE as of Q3 2026.

  • Geneos Wealth Management held 200 shares of Strive Emerging Markets ex-China ETF worth $9.9K as of Q3 2026.
  • Geneos Wealth Management left its Strive Emerging Markets ex-China ETF share count unchanged in Q3 2026.
  • Strive Emerging Markets ex-China ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2388 holding.
  • Geneos Wealth Management first reported a position in Strive Emerging Markets ex-China ETF in Q4 2024 and has held it in 8 quarters since.
  • Geneos Wealth Management's Strive Emerging Markets ex-China ETF position peaked at $10.5K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Strive Emerging Markets ex-China ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.